Completing the circle
Subject to the approval of the shareholders and the usual regulatory and statutory rubber stamps, India's largest pharmaceutical company, Ranbaxy Laboratories, is expected, by the end of March 2009 to become a subsidiary of Daiichi Sankyo, one of the leading pharmaceutical companies of Japan. Ranbaxy came into existence in 1937 as the local distributor for a Japanese pharmaceutical company, was taken over by Bhai Mohan Singh in 1952, undertook the transition from trading to manufacturing a few years before the Indian Patents Act (IPA) of 1970 came into effect, and then took full advantage of the provisions of that law to become a leading transnational corporation in the generics segment of the world pharmaceutical industry. (Editorial)
Related Content
- Order of the High Court of Uttarakhand regarding sewage disposal in Ganga due to non completion of project by Uttarakhand Irrigation Department, 03/08/2022
- COVID-19 Global Humanitarian Response Plan
- With Carbon Dioxide Concentrations Nearing New Highs, 2020 Will Be ‘Make It or Break It Year’ for Climate Action, Secretary-General Warns
- SC puts complete ban on felling of trees in Himachal Pradesh
- Air quality monitoring in Bengaluru completes 35 years
- With anti-poaching squad defunct, wildlife trade flourishes